In that regard, via a significant decrease in serum PAI-1 in Obe group, Api supplementation could indirectly prevent the previously mentioned obesity-associated thrombotic complications. The gene discussed is SERPINE1; the disease is obesity due to melanocortin 4 receptor deficiency.